MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results - Marketscreener.com
| SIDO Stock | IDR 580.00 10.00 1.75% |
About 53% of Sido Muncul's institutional investors are presently thinking to get in. The analysis of current outlook of investing in Sido Muncul PT suggests that some traders are interested regarding Sido Muncul's prospects. Sido Muncul's investing sentiment shows overall attitude of investors towards Sido Muncul PT.
Sido |
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results Marketscreener.com
Read at news.google.com
 |
Sido Muncul Fundamental Analysis
We analyze Sido Muncul's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sido Muncul using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sido Muncul based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Sido Muncul is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Sido Muncul PT Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sido Muncul stock to make a market-neutral strategy. Peer analysis of Sido Muncul could also be used in its relative valuation, which is a method of valuing Sido Muncul by comparing valuation metrics with similar companies.
Peers
Sido Muncul Related Equities
| KLBF | Kalbe Farma | 0.67 |
| ||
| AKRA | Akr Corporindo | 2.77 |
|
Other Information on Investing in Sido Stock
Sido Muncul financial ratios help investors to determine whether Sido Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sido with respect to the benefits of owning Sido Muncul security.